Objective: To evaluate the efficacy of a multiple micronutrient fortified beverage containing eleven nutrients at physiological levels in prevention of anaemia and improving iron and vitamin A status during pregnancy. Design: A randomised double blind placebo controlled study. Setting: Mpwapwa and Kongwa Districts in Dodoma Region of Tanzania. Subjects: Five hundred and seventy nine pregnant women were screened for entry into the study and 439 women who met the study criteria were enrolled. Interventions: Study participants received either a fortified (F) or non-fortified (NF) orange flavoured drinks identical in appearance, provided in two self administered servings per day for an eight week period.
INTRODUCTION
The World Health Organisation (WHO) estimates that 35% to 75% of pregnant women in developing countries and 18% of women from industrialised countries become anaemic during pregnancy(]). In Tanzania, the prevalence of anaemia lies between 36% to over 75% of pregnant women, and it is shown to vary with altitude, being very prevalent along the coastal belt (2) (3) (4) (5) .
The common cause of nutritional anaemia is iron deficiency, although there is evidence to suggest that deficiencies of B 12, folate, vitamin A and zinc contribute either singly or in combination to maternal anaemia (6) (7) (8) . Furthermore dependence on cereal and legume based diets, which often lack animal protein as well as fruits and vegetables that enhance absorption of nonhaem iron aggravate the condition. Increased iron requirements during pregnancy, and prevalence of parasitic infections such as hookworm and schistosomiasis further predisposes to severe anaemia in the poor countries. Malaria also contributes to anaemia in childbearing women. As a result maternal mortality and adverse pregnancy outcomes such as
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foetal loss, prematurity and low birth weight are increased (9,lO) . This calls for correction of pregnancy induced iron deficiency anaemia otherwise women will suffer the described consequences. In Tanzania prophylaxis against nutritional anaemia have focussed on mainly combating iron deficiency anaemia. Use of iron supplements as recommended by the WHO guidelines(l1) has been implemented throughout the country. Iron tablets are distributed free of charge in government clinics that provide antenatal care. Despite this measure the prevalence of anaemia during pregnancy has remained high due to low compliance, logistic problems and inadequate knowledge of primary health worker on how to instruct women on use of haematinics(l2-14). Since women with anaemia during pregnancy also suffer multiple nutritional deficiencies, the use of multiple micronutrient supplements is being advocated as an alternative measure(l5-17). The objective of this study was to evaluate the efficacy of one such multiple micronutrientfortified beverage in improving haemoglobin level in two rural districts of central Tanzania.
MATERIALS AND METHODS
to 250 ml of clean previously boiled water to produce a single serving. Each subject was asked to drink two sachets daily, one with the morning meal and another with an evening meal. The women collected their supplies fortnightly. All the empty packages were returned and counted before providing a new supply every two weeks. Table 1 Quantities of nutrients in the fortified beverage consumed daily compared with the FAONHO recommended daily allowances during third trimester of pregnancy
The study was conducted between the months of August and Ikcember 1999 in study subjects predominantly the lFAONHO ~~~~~ dietary allowances (RDA) and Wagogo and Wakaguru of Mpwapwa and Kongwa Districts intakes for pregnant of Dodoma Region, Tanzania. The area is semi-arid and 2~o w iron bioavailability=diet categorised as having iron agricultural production is usually seasonal.
absorption of about 5%. The study subjects were mothers of gestational age between 10 aid 34 -weeks. A maximum age bf NB: The beverage had less iron content than RDA by the 34 weeks was chosen to ensure that mothers had at least eight WHOFAO weeks of supplementation before delivery. Eligibility criteria RE=Retinol equivalent, TE= ( , -tocopherol equivalents.
included Hb greater than or equal to 8.0g/dL and absence NE=Niacin equivalents of a serious medical disorder during the current pregnancy. Out of 579 pregnant women who were screened for enrolment, only 439 met the study criteria.
The study was approved by the Research and Ethics Committee of the Tanzania Food and Nutrition Centre, as well as by Comell University Committee on human Subjects. Informed consent was obtained from the study participants.
The study design was a double blind placebo controlled trial with two groups. Sample size was calculated using a haemoglobin difference of 0.8g/dL, with a power of 80% and a confidence level of 95%. After adjusting for a 25% potential drop out rate each of the two groups required 21 1 participants. At each of the study centres a block randomisation (ten subjects in each block) was used to assign the pregnant women to one of the two study groups i.e., receiving fortified beverage (F group) and receiving non-fortified beverage (NF group).
The micronutrient fortified beverage produced by food technologists at the Procter & Gamble Company, contained eleven nutrients. Most of the doses of micronutrients in the beverages were lower than recommended daily allowances for supplements during pregnancy. The nutrients include: iron, vitamin A, iodine, zinc, vitamin C, riboflavin, folic acid, vitamin B12, vitamin B6. Niacin and vitamin E, shown in Table I with reference to the FAOANHO recommended levels, under results. The content of one sachet was added Laboratory measurements were taken at baseline and after eight weeks. Whole blood collected by venepuncture was used for haemoglobin determination. Haemoglobin was measured by a portable haemoglobinometer (HemoCue AB, Angelholm. Sweden). Serum ferritin (SF) was assayed via an enzyme-linked immunosorbent assay according to the method described by Flowers et. al., 1989 using commercial kits (Ramco Laboratories. Houston, Texas. USA). Accuracy was assessed using a quality control sera (Ramco Laboratories. Houston, Texas, USA and Lyphochek lmmunoassay Plus Controls from Bio-rad Laboratories, Hercules, California). For all assays, samples were assayed in duplicate to measure within-run precision, and aliquots of pooled serum were used to measure inter-assay precision. Liquid Nitrogen was used to transport frozen sera from field to the laboratory for storage until analysis. Fresh urine and stool samples were collected for Schistosomiasis and hookworm ova examination. Stool preparations and urine deposits after centrifugation were examined microscopically.
Weight, height, height of the fundus and gestational age were established by a medical doctor. A questionnaire was administered to collect information on health, nutrition, morbidity and demographic factors.
Data was analysed in SPSS programme (SPSS 1999).
.
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November 2002 Comparisons of continuous variables between groups were made using independent t-test if the variables were normally distributed. Mann-Whitney U-tests was used for non-normal data, the chi-square test were used for comparison of categorical variables including anaemia status between the two treatment groups and change in anaemia status after treatment. Before and after comparisons using normally distributed continuous data were completed using dependent t-tests. For categorical data the Sign and McNemar tests were used. Multivariate analysis was done using multiple regression for continuous dependent variables, binary logistic regression for categorical outcomes with more than two levels. One way ANOVA was used when the comparison was being made between three groups. Treatment codes were broken only after all the data analysis had been completed.
RESULTS
Of the study 579 mothers screened, 439 mothers who met the entry criteria were enrolled in the study and 259 (58.9%) who had not delivered (129 in the fortified and 130 in the non-fortified) were included in post-intervention assessments at the eighth-week. There were no significant differences in biochemical as well as anthropometric measurements in the two groups before intervention.
Haemoglobin and ferritin changes between examination 1 and 2:
The results in Table 2 show that used fortified beverage (F group) had a significant mean increase of haemoglobin concentration of 0.86M.02 g/dL and the final group mean Hb was 1 1.4M. lg/dL. There was also a significant increase of 0.45M.OlgldL in mean Hb in the group given non-fortified beverage (NF group), with the mean Hb at exam 2 of 10.9H.1 g/dL. The increase in Hb experienced by the F-group was significantly higher than the increase experienced by the NF-group (median difference 0.4m.01 g/dL, p=0.02). The F group also experienced a significant increase of serum ferritin at follow up than the NF-group (22.7f 1.1 versus 18.5+1.lg/dL, p=0.05). The mean ferritin in the Fgroup at follow up was, 4.2 pg/dL higher than that in the N-group (p=0.009). The F-group experienced a small but significant increase in ferritin of 3pgIdL (p=0.012) while the NF-group had a non-significant decrease of 2pgIdL (p=O. 166).
The changes in serum retinal was less marked. However, serum retinol for those who were having normal levels before intervention increased by 0.14pmol/ dL in the F-group and decreased by 1.2pmol/dL in the NF-group. The main difference of 0.26 pmol/dL was significant (p<0.05).
Gestational age and supplement interaction:
The gestational age was positively associated with changes in Hb (r=0.153, p=0.036, n=188) . The biggest increase in overall Hb occurred in-mothers who were in the second (0.77g/dL to I. l3g/dL, p<0.0001) and third (0.69 to 1.06 g/dL, p<0.0001) trimester of gestational age at entry into the study. However F group mothers in the first and second trimester experienced a much greater increase in Hb when compared to NFgroup. The difference in the increase in the third trimester was small and non-significant. A significant interaction was also found between treatment group and gestational age and was also confirmed by multivariate analysis. Table 3 shows that in the stepwise multiple regression model the important predictors of Hb increase, included being in the F-group, baseline Hb, baseline serum retinol, c-reactive protein (CRP), baseline ferritin and gestational age at entry into the study. The interaction term between treatment group and gestational age was significant and negatively associated with change in Hb. The most important predictors of Hb increase in order of importance were the treatment, treatment x gestational age interaction, and Hb at entry and gestational age. According to this model the effect of treatment on change (increase) in Hb was modified by the gestational age of the mother at entry into study.
Predictors of change in haemoglobin
In mothers who were about 19 weeks of gestation at entry into the study the difference was about 0.8gldL and in those who were 29 weeks it was O.Mg/dL.
Prevalence of anaemia and iron deficiency at exam I and 2
The prevalence of mothers with anaemia in the F(n=127) and NF (n=132) groups were 63.8% and 59.1% respectively (p=0.438) at entry into the study. However at follow up, the F group had a significantly lower proportion of anaemic mothers when compared to the NF-group (37% vs 48.5%, p=0.019). The F-group mothers experienced a significant change in anaemia status (McNemar x 2=22.674, n= 127, p=0.000) but change within the NF-group mothers was not significant. Logistic regression analysis showed that treatment had an effect on the risk of being anaemic at the end of eight weeks of supplementation. After adjusting for anaemia and vitamin A status at entry into the study mothers in the fortified group had a 5 1 % decrease in the risk of being anaemic (Table 4) . 
Effect of supplement on iron stores at exam 2
The effect of the supplement on post-intervention femtin or change in ferritin seemed to depend on the level of baseline ferritin. The effect of the supplement was more pronounced in those mothers who had higher ferritin levels or were iron replete at entry where it prevented significant decrease in ferritin levels. At exam 2 mothers with depleted iron stores at entry had remained iron depleted or their iron stores improved. Those with adequate iron stores had either remained iron replete or became iron depleted. The F-group mothers experienced a significant change of iron status ( X2=5.63, p=0.000). There was no significant change in iron status within mothers assigned to the NF-group.
Vitamin A status of anaemic pregnant women Serum retinol at baseline, eight weeks follow up and post partum did not differ according to treatment group. When the analysis was restricted only to mothers who had delivered at the eighth week follow up postpartum serum retinol level was significantly higher than both the baseline (O.Slpmol/dL, p=0.000) and the eighth week follow up (0.71pmoVdL, p=0.000) levels. There was a positive correlation between follow up serum retinol and baseline serum retinol among mothers who had not delivered at follow up (R=0.33, p=0.000, n=242).
DISCUSSION
The results from this study show that multiple micronutrient supplementation during pregnancy results in improved iron status. There was a significantly higher increase in concentration of up to 0.8g/dL, over the eight weeks of supplementation in favour of the group that consumed the fortified beverage. After adjusting for possible confounding factors, this increase was highest in those mothers who had earlier gestational ages at entry into the study. Given the smaller doses of iron contained in the micronutrient-fortified beverage when compared to the larger doses used in most iron supplementation trials, this increase was quite reasonable. In controlled supplementation trials with larger doses of 90 to 120 mg of iron supplements increases of between 1.2 and 1.6gldL have been reported (16, 22) .
Since most of the micronutrients contained in the fortified beverage are essential for haemoglobin synthesis it was not possible to distinguish or separate the effects of the various micronutrients on the increase in haemoglobin. Micronutrients such as vitamin B12, folate, vitamin A and iron are all essential for haemoglobin synthesis. An evaluation of the indicators of iron (serum femtin) and vitamin A (serum retinol) status on haemoglobin change showed a positive association between baseline serum retinol and an increase in haemoglobin at the end of the study. This suggests that mothers with higher vitamin A concentrations at entry into the study were more likely to experience an increase in haemoglobin at the end of the study regardless of the treatment group they had been assigned to. According to the multivariate model a 1 unit (pmol1dL) increase in serum retinol will be associated with a 0.53 g/dL in haemoglobin increase. There was no significant association between follow up vitamin A and change in haemoglobin, neither was there any association between change in vitamin A and change in haemoglobin. The finding of a significant positive association between vitamin A and haemoglobin increase is consistent with findings from iron and vitamin A supplementation trials in which a combination of iron and vitamin A resulted in a significantly higher increase in haemoglobin than when iron was given alone (8, 15, 17) .
Baseline haemoglobin was negatively associated with increase in haemoglobin. This finding is consistent with findings from other supplementation trials in which supplemented pregnant mothers with low baseline haemoglobin concentration experienced a higher increase in haemoglobin than supplemented mothers with higher haemoglobin levels(l8). The beneficial effect of the micronutrient-fortified beverage on increase in haemoglobin was more pronounced in the mothers who were at earlier gestations at entry into the study. This finding reflects the pregnancy-induced increase in red blood cell formation, which tends to lead to an increase in haemoglobin during the third trimester of pregnancy(l7,18). Requirements for absorbed iron tend to vary with the gestational age of the pregnancy being low in the first and higher during the second and third trimester(l9,21). This was also reflected in our study and the finding suggests that if physiological doses are to be used for iron supplementation then the best results will be obtained if supplementation is started earlier rather than later in pregnancy. Starting the supplementation early would ensure that the pregnant women took the supplement for a longer period of time. The women who had low ferritin (ferritin <30 mg/L) at entry into study had a 0.44gldL lower increase in haemoglobin than those who had higher ferritin concentrations. This finding suggests that mothers with lower initial iron stores (as indicated by low ferritin levels) experienced a lesser increase in haemoglobin irrespective of the treatment group to which they have been allocated. The reduction in the risk of being iron deficient was more pronounced in those mothers who had adequate iron stores at entry into the study. After adjusting for both anaemia and vitamin A status at entry into the study, the micronutrient fortified beverage reduced the risk of being anaemic at the end of the study by 5 1 % in mothers receiving the fortified beverage when compared to those who received the non-fortified beverage.
Both treatment groups experienced a significant increase in haemoglobin from baseline to follow up. This increase could have been due to a number of factors such as a decline in malarial infections and an .
EAST AFRICAN ME1 DlCAL JOURNAL 603 increase in intake of foods with more bioavailable iron and other micronutrients. The study was conducted from August to December, which is just after the malarial season and soon after harvest time. During this time local farmers would still have access to their produce and would have more money for food from selling some of the produce. Studies conducted in Malawi(l0) and Kenya(20) have both demonstrated that seasonal variation has an effect on anaemia and haemoglobin concentrations. Our findings shows the benefits of this multiple micronutrient-fortified beverage on controlling anaemia during pregnancy and depending on gestational age 0.04 to 0.80 g/dL increase in haemoglobin concentration can be achieved. However this is not a strategy to replace the regular use of haematinics but rather is an alternative in circumstances like this where compliance is a problem with the conventional method. Compliance with this beverage was good and was shown by the number of mothers who were seen at follow up with few reported complaints. This was also reported by the anthropological part of our study which showed that women asked their husbands to go and collect the supplement for them when they were unable to do so.
